X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

Amcor launches enhanced heat seal coating healthcare packaging solution

Content Team by Content Team
7th June 2021
in Packaging & Logistic, Press Statements
Amcor launches enhanced heat seal coating healthcare packaging solution

Amcor, a global packaging leader, is introducing ACT2100 heat seal coating for medical grade DuPont™ Tyvek and paper packaging applications. This next generation coating technology delivers enhanced performance features for healthcare applications and will be produced in multiple locations worldwide to offer customers the flexibility to receive supply from the most suitable location for the manufacturing and packaging of their devices.

“We are thrilled to introduce ACT2100™ after two years of research and development,” said Amcor Healthcare Packaging Rollstock Product Manager Ryan Brunk. “Our engineers have made great strides to respond to the evolving requests of our healthcare customers with ACT2100™. We’re particularly pleased to manufacture this product in multiple sites across the globe creating a simpler supply chain and supporting our customers with stronger business continuity options.”

Customers choosing ACT2100™ will benefit from the solution’s broader seal range in combination with many materials, which allows for a wider operating window in customers’ manufacturing operations, as well as enhanced seal strength for more robust package integrity through distribution.

Consumers will enjoy speedier ethylene oxide sterilization cycles thanks to the material’s improved porosity, a fibre-free peel, and a bright, white adhesive that does not yellow. In addition, documentation and data will be available to support healthcare packaging regulatory requirements in all regulated markets.

All Amcor paper and Tyvek adhesive products are available with a wide range of companion materials. ACT2100™ heat seal adhesive will be added to Amcor’s existing portfolio of well-known, high-performance Tyvek adhesives including CR27® and SBP2000® heat seal coatings. This allows customers to choose to leverage historic validations with legacy products or use ACT2100™ for newer requirements.

This exciting innovation builds on Amcor’s reputation for high-quality, reliable performance heat sealing adhesives for medical grade papers and Tyvek material, including Amcor’s CR27® adhesive, which has been an industry standard and highly trusted for nearly four decades. ACT2100™ has been developed leveraging the best of CR27® with improvements that are aligned with our customer’s continuously evolving requirements.

About Amcor

Amcor is a global leader in developing and producing responsible packaging for food, beverage, pharmaceutical, medical, home- and personal-care, and other products. Amcor works with leading companies around the world to protect their products and the people who rely on them, differentiate brands, and improve supply chains through a range of flexible and rigid packaging, specialty cartons, closures, and services. The company is focused on making packaging that is increasingly light-weighted, recyclable and reusable, and made using an increasing amount of recycled content. Around 47,000 Amcor people generate US$12.5 billion in sales from operations that span about 230 locations in 40-plus countries.

Previous Post

Thailand LAB INTERNATIONAL & Bio Asia Pacific will go ahead as planned!

Next Post

Peli BioThermal adds Service Offerings for Single-Use Products

Related Posts

ACHEMA
Middle East and South Asia

ACHEMA Middle East to Debut in Riyadh in 2026 Trade Show

9th May 2025
Press Statements

APM Steam Highlights Comprehensive HVAC Insulation Services for Biopharmaceutical and Pharmaceutical Facilities

19th April 2025
Healthcare Packaging
Asia

Amcor Healthcare Packaging Expansion in Asia Pacific

16th April 2025
Americas

Thermo Fisher to acquire Solventum’s Purification & Filtration business for US$4.1bn

4th March 2025
Drug Development

Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

4th March 2025
Drug Development

Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

4th March 2025
Next Post
Peli BioThermal adds Service Offerings for Single-Use Products

Peli BioThermal adds Service Offerings for Single-Use Products

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In